SCHEMBL7987434

SCHEMBL7987434

CCc1nc(O)c2c(ncn2Cc2ccc(C)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.42
CYP11B2 P19099 3/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
MET P08581 3/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
NR3C1 P04150 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989377 0.91 LMNA (0.44) CYP11B1CYP11B2LMNASMN1; SMN2HTT
SCHEMBL7988129 0.91 MET (0.44) LMNASMN1; SMN2METHPGDKMT2A
SCHEMBL7984526 0.88 MET (0.46) CYP11B1CYP11B2SMN1; SMN2HTTMET
SCHEMBL7975252 0.88 HPGD (0.45) CYP11B1CYP11B2SMN1; SMN2HPGDMEN1
SCHEMBL7984378 0.88 CYP11B1 (0.42) CYP11B1CYP11B2SMN1; SMN2METHPGD
SCHEMBL8059823 0.86 MEN1 (0.45) SMN1; SMN2TP53MAPTHPGDMEN1
SCHEMBL7973934 0.86 CYP11B1 (0.45) CYP11B1CYP11B2SMN1; SMN2METHPGD
SCHEMBL7975137 0.86 LMNA (0.42) CYP11B1CYP11B2LMNASMN1; SMN2HTT
SCHEMBL7984468 0.86 ABCC8 (0.46) CYP11B1CYP11B2LMNASMN1; SMN2MET
SCHEMBL7988035 0.86 SMN1; SMN2 (0.39) CYP11B1CYP11B2LMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed